GILEAD SCIENCES, INC. Current Liabilities 2008-2026 | GILD
Beta
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is GILEAD SCIENCES, INC.'s current current liabilities?
GILEAD SCIENCES, INC. (GILD) annual current liabilities for 2025 was $11.81B, a 1.59% decline from 2024. GILEAD SCIENCES, INC. current liabilities for the quarter ending March 31, 2026 was $9.48B.
What was GILEAD SCIENCES, INC.'s current liabilities in 2024?
GILEAD SCIENCES, INC. annual current liabilities for 2024 was $12.00B, a 6.42% increase from 2023.
What was GILEAD SCIENCES, INC.'s current liabilities in 2023?
GILEAD SCIENCES, INC. annual current liabilities for 2023 was $11.28B, a 0.38% increase from 2022.
What is GILEAD SCIENCES, INC.'s 5-year current liabilities CAGR?
GILEAD SCIENCES, INC. current liabilities grew at a compound annual growth rate (CAGR) of 0.72% from FY2020 to FY2025, going from $11.40B to $11.81B over 5 years.
Current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+0.7%
FY2020
$11.40B
→
FY2025
$11.81B
080910111213141516171819202122232425
5 years selected
Current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $11.81B | -1.6% | 10-K |
| FY2024 | $12.00B | +6.4% | 10-K |
| FY2023 | $11.28B | +0.4% | 10-K |
| FY2022 | $11.24B | -3.2% | 10-K |
| FY2021 | $11.61B | +1.9% | 10-K |
| FY2020 | $11.40B | +16.8% | 10-K |
| FY2019 | $9.76B | -8.0% | 10-K |
| FY2018 | $10.61B | -8.9% | 10-K |
| FY2017 | $11.63B | +26.2% | 10-K |
| FY2016 | $9.22B | -6.8% | 10-K |
| FY2015 | $9.89B | +71.7% | 10-K |
| FY2014 | $5.76B | -10.1% | 10-K |
| FY2013 | $6.41B | +51.2% | 10-K |
| FY2012 | $4.24B | +68.5% | 10-K |
| FY2011 | $2.51B | +2.0% | 10-K |
| FY2010 | $2.46B | +31.7% | 10-K |
| FY2009 | $1.87B | +53.3% | 10-K |
| FY2008 | $1.22B | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →